Skip to main content

7 in 7 healthcare insights: from Bell Potter’s Healthcare conference in Sorrento

Bell Direct
March 18, 2025

Our Market Analyst, Grady Wulff, recently had the opportunity of attending Bell Potter’s Healthcare Conference in Sorrento, Melbourne, where they engaged in in-depth discussions with seven executives from some of Australia’s most promising emerging healthcare companies.

View the full interviews below:

  1. From the Helm: QBiotics Group Limited General Counsel, Ebru Davidson
  2. From the helm: Clarity Pharmaceuticals (ASX:CU6), Executive Chairperson, Alan Taylor
  3. From the helm: Orthocell Limited (ASX:OCC), CEO & Managing Director, Paul Anderson
  4. From the helm: Neuren Pharmaceuticals (ASX:NEU), Chief Executive Officer, Jon Pilcher
  5. From the helm: EBR Systems (ASX:EBR), CEO & President, John McCutcheon
  6. From the helm: Imugene (ASX:IMU) CEO & Managing Director, Leslie Chong
  7. From the helm: Immutep (ASX:IMM) CEO & Managing Director, Marc Voigt